Slideshow
-
#9: "FDA Lifts Restrictions on Rosiglitazone-Containing Drugs"
-
#3: "First FDA-Approved Non-Hormonal Therapy for Hot Flashes Available"
-
#10: "New JNC 8 Hypertension Guidelines: What Does the Panel Recommend Now?"
-
#5: "FDA Approves Diclegis for Morning Sickness; First Treatment OK'd in 30 Years"
-
#8: "ACC/AHA Release New Guidelines on Management of CVD Risk"
-
#4: "Invokana, First in New Class of Diabetes Drugs, Approved"
-
#1: "First Artificial Pancreas with Low Glucose Suspend System Approved for Diabetics"
-
#6: "FDA Approves OTC Oxytrol Patch for Women"
-
#7: "Plan B One-Step OTC Officially Approved for All"
-
#2: "Zecuity Skin Patch Approved for Migraine Treatment"
Here are ten news stories that had an impact with MPR readers in 2013.
#1: “First Artificial Pancreas with Low Glucose Suspend System Approved for Diabetics”
#2: “Zecuity Skin Patch Approved for Migraine Treatment”
#3: “First FDA-Approved Non-Hormonal Therapy for Hot Flashes Available”
#4: “Invokana, First in New Class of Diabetes Drugs, Approved”
#5: “FDA Approves Diclegis for Morning Sickness; First Treatment OK’d in 30 Years”
#6: “FDA Approves OTC Oxytrol Patch for Women”
#7: “Plan B One-Step OTC Officially Approved for All”
#8: “ACC/AHA Release New Guidelines on Management of CVD Risk”
#9: “FDA Lifts Restrictions on Rosiglitazone-Containing Drugs”
#10: “New JNC 8 Hypertension Guidelines: What Does the Panel Recommend Now?”